Clinical Trial

Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028

Debt-Free Balance Sheet With $21.6 Million in CashBROOMFIELD, Colo., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the…

4 weeks ago

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

January 13, 2026, 7:00 AM CET  Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company…

4 weeks ago

Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences

Kuros Biosciences to provide investor updateat Octavian and Baader Bank Conferences Schlieren (Zürich), Switzerland, January 13, 2026 – Kuros Biosciences…

4 weeks ago

Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis

Consumer searches for supplement legitimacy increased 26% year-over-year as transparency becomes central purchasing criterion — industry analysis examines what drives…

4 weeks ago

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients.Activation of additional…

4 weeks ago

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection

– Collaboration is designed to improve analytical speed and accuracy of Freenome's blood-based cancer screening tests – BRISBANE, Calif., Jan. 12, 2026…

4 weeks ago

Suvoda sets new standard for streamlined patient and site experience in clinical trials

CONSHOHOCKEN, Pa., Jan. 12, 2026 /PRNewswire/ -- Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a…

4 weeks ago

RealTime eClinical Solutions Appoints Jeff Kozloff as Chief Executive Officer to Accelerate Next Phase of Growth and Innovation

SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- RealTime eClinical Solutions, a leader in clinical research software technology, today announced that…

4 weeks ago

CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan…

4 weeks ago